CEO & Manager Board of Directors
 
Eileen Westerman has served as CEO and the Manager of the Board of Directors since 2017. She has been with Intrinsic since 2011 first in the capacity of Regulatory Affairs Manager as well as of Executive Assistant to the CEO from 2015 on. Prior to …Read More

 

 

 

 

 

 

 
Bio - Vaugn OstlandVaughn Ostland Ph.D.,
Co-Founder
Chief Operations Officer

 

Vaughn Ostland PhD has served as Chief Operations Officer since early 2009. Dr. Ostland is a founding member of Intrinsic LifeSciences, co-inventor of the hepcidin patents, and is responsible for a wide range of management and R&D duties.  He currently dedicates his efforts   …Read more

 
Bio - James WestermanJames Westerman CPA,
Chief Financial Officer

 

 

James Westerman holds degrees from Texas A&M University in Economics and Finance and began his career in the oilfield services industry with Dresser and Hughes  Read more

 
Bio - Tomas GanzTomas Ganz Ph.D.,
Co-Founder
Chief Medical Officer
Professor, David Geffen School of Medicine,
UCLA

 

Tomas Ganz is a co-founder of Intrinsic LifeSciences. He holds a Ph.D. in Applied Physics from the California Institute of Technology and an M.D. from UCLA. Tom trained in Internal Medicine and Pulmonary  Read more

 
Co-Founder
Chief Scientific Officer
Professor, David Geffen School of Medicine,
UCLA

 

Elizabeta Nemeth is a co-founder of Intrinsic LifeSciences. She holds a Ph.D. in Molecular, Cellular and Neurosciences from the University of Hawaii. Elizabeta joined UCLA in 2002 Read more

 
Bio - Gordana OlbinaGordana Olbina Ph.D.,
Laboratory Director

 

 

Gordana Olbina is Laboratory Director at Intrinsic LifeSciences. As the first employee of ILS, she initially worked on validation of the original Hepcidin RUO test and contributed to numerous research collaborations. She successfully developed and implemented the policies and procedures required to   Read more

 
Huiling Han M.D.,
R&D Director

 

Huiling Han (MD) is the R&D Director at ILS. She has been working for ILS for more than 10 years, and her research in hybridoma cell lines and polyclonal antibodies led to the launch of all commercial ELSA kits and CLIA tests at ILS. She also  …Read More